KFS
IBB icon

KMS Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

KMS Financial Services’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3.72M Buy
40,770
+531
+1% +$46.6K 0.52% 42
2014
Q2 		$3.45M Buy
40,239
+16,725
+71% +$1.32M 0.49% 45
2014
Q1 		$1.85M Buy
23,514
+9,258
+65% +$771K 0.29% 85
2013
Q4 		$1.08M Buy
14,256
+4,386
+44% +$311K 0.18% 130
2013
Q3 		$690K Buy
9,870
+2,943
+42% +$193K 0.17% 148
2013
Q2 		$401K Buy
+6,927
New +$400K 0.11% 219

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

KMS Financial Services's IBB Position: Q3 2014 in Review

KMS Financial Services increased its iShares Biotechnology ETF (IBB) stake by 1.3% in Q3 2014, buying an estimated $46.6K and bringing the position to 40,770 shares worth $3.72M. The position accounts for 0.52% of the portfolio, ranked #42.

KMS Financial Services first reported a position in IBB in Q2 2013 and has held it in 6 quarters since. 317 funds tracked by Wall St. Rank hold IBB as of Q3 2014.

  • KMS Financial Services held 40,770 shares of iShares Biotechnology ETF worth $3.72M as of Q3 2014.
  • KMS Financial Services bought 531 iShares Biotechnology ETF shares in Q3 2014, an estimated $46.6K.
  • iShares Biotechnology ETF made up 0.52% of KMS Financial Services's portfolio in Q3 2014, its #42 holding.
  • KMS Financial Services first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 6 quarters since.
  • 317 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2014.

Based on KMS Financial Services's 13F filing for Q3 2014, filed 14 Nov 2014.